References
- National Institute of Health, National Institute on Drug Abuse. Overdose death rates. Bethesda (MD): Office of Science Policy and Communications, Digital Communications Branch; 2019 [accessed 2019 Sept 23]. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates.
- Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple cause of death 1999–2017: National drug overdose deaths involving select prescription and illicit drugs 1999–2017 [dataset]. 2018 Dec 6 [cited 2019 Nov 6]. In: CDC WONDER Online Database [Internet]. Available from: http://wonder.cdc.gov/mcd-icd10.html.
- Rudd RA, Seth P, Scholl D. Increases in drug and opioid-involved overdose deaths –United States, 2010–2015. Atlanta (GA): Centers for Disease Control and Prevention; 2016. Dec 30. MMWR Morb Mortal Wkly Rep 655051. [accessed 2019 Sept 23]. 10.15585/mmwr.mm655051e1.
- Kim D, Irwin KS, Khoshnood K. Expanded access to naloxone: Options for critical response to the epidemic of opioid overdose mortality. Am J Public Health. 2009; 99(3):402–7. doi:10.2105/AJPH.2008.136937. Cited in: PMID: 19150908.
- National Institute of Health, National Institute on Drug Abuse. Naloxone for opioid overdose: life-saving science. Bethesda (MD): Office of Science Policy and Communications, Digital Communications Branch; 2017 [accessed 2019 Sept 23]. https://www.drugabuse.gov/publications/naloxone-opioid-overdose-life-saving-science/naloxone-opioid-overdose-life-saving-science.
- Hall WD, Farrell M. Reducing the opioid overdose death toll in North America. PLoS Med. 2018; 15(7):e1002626–3. Jul; Cited by: PMID: 30063698. doi:10.1371/journal.pmed.1002626.
- Giglio RE, Li G, DiMaggio CJ. Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis. Inj Epidemiol. 2015; 2(1):1–9. doi:10.1186/s40621-015-0041-8.
- Adams JM. Increasing naloxone awareness and use: the role of health care practitioners. JAMA. 2018; 319(20):2073–4. doi:10.1001/jama.2018.4867.
- Kerensky T, Walley AY. Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t. Addict Sci Clin Pract. 2017; 12(1):1–7. doi:10.1186/s13722-016-0068-3.
- Heavey SC, Chang Y-P, Vest BM, Collins RL, Wieczorek W, Homish GG. 'I have it just in case' - Naloxone access and changes in opioid use behaviours. Int J Drug Policy. 2018 ;51:27–35. doi:10.1016/j.drugpo.2017.09.015. Cited in: PMID: 29156400.
- Gunn AH, Smothers ZPW, Schramm-Sapyta N, Freiermuth CE, MacEachern M, Muzyk AJ. The emergency department as an opportunity for naloxone distribution. West J Emerg Med. 2018; 19(6):1–7. doi:10.5811/westjem.2018.8.38829.
- Darke S, Mills KL, Ross J, Teesson M. Rates and correlates of mortality amongst heroin users: Findings from the Australian treatment outcome study (ATOS), 2001–2009. Drug Alcohol Depend. 2011 ;115(3):190–5. doi:10.1016/j.drugalcdep.2010.10.021.
- Olfson M, Wall M, Wang S, Crystal S, Blanco C. Risks of fatal opioid overdose during the first year following nonfatal overdose. Drug Alcohol Depend. 2018; 190:112–9. doi:10.1016/j.drugalcdep.2018.06.004.
- Maryland Behavioral Health Administration. Unintentional drug-and-alcohol-related intoxication deaths in Maryland annual report. Baltimore (MD): Maryland Department of Health; 2017. Drug and Alcohol-Related Intoxication Deaths in Maryland, 2017 annual report [accessed 2019 Sept 23]. https://bha.health.maryland.gov/OVERDOSE_PREVENTION/Documents/Drug_Intox_Report_2017.pdf.
- National Institute of Health, National Institute on Drug Abuse. Maryland opioid summary - opioid-involved overdose deaths. Bethesda (MD): Office of Science Policy and Communications, Digital Communications Branch; 2019 [accessed 2019 Sept 23]. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-summaries-by-state/maryland-opioid-summary.
- Office of Governor Larry Hogan. Hogan-Rutherford administration declares state of emergency, announces major funding to combat heroin and opioid crisis in Maryland. Annapolis (MD): Office of the Governor; 2017 [accessed 2019 Sept 23]. http://governor.maryland.gov/2017/03/01/hogan-rutherford-administration-declares-state-of-emergency-announces-major-funding-to-combat-heroin-and-opioid-crisis-in-maryland/.
- Morgan J, Jones AL. The role of naloxone in the opioid crisis. Toxicology Communications. 2018; 2(1):15–8. doi:10.1080/24734306.2018.1458464.
- Maryland Behavioral Health Administration. Overdose prevention in Maryland. Baltimore (MD): Maryland Department of Health; 2018. [accessed 2019 Sept 23]. https://bha.health.maryland.gov/OVERDOSE_PREVENTION/Pages/Index.aspx.
- Stata Statistical Software. Version 15.0 [software]. College Station (TX): StataCorp LP; 2017.
- Ventura AS, Bagley SM. To improve substance use disorder prevention, treatment and recovery: Engage the family. J Addict Med. 2017; 11(5):339–41. doi:10.1097/ADM.0000000000000331.
- Pollini RA, McCall L, Mehta SH, Vlahov D, Strathdee SA. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2006;83(2):104–10. doi:10.1016/j.drugalcdep.2005.10.015.
- Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. The burden of opioid-related mortality in the United States. JAMA Netw Open. 2018;1(2):e180217. doi:10.1001/jamanetworkopen.2018.0217.
- Lippold KM, Jones CM, Olsen EO, Giroir BP. Racial/ethnic and age group differences in opioid and synthetic opioid-involved overdose deaths among adults aged ≥18 years in metropolitan areas - United States, 2015–2017. MMWR Morb Mortal Wkly Rep. 2019;68(43):967–73. DOI: http://dx.doi.org/10.15585/mmwr.mm6843a3externalicon. doi:10.15585/mmwr.mm6843a3.
- Harm Reduction Coalition. Principles of harm reduction. New York (NY): Firefly Partners; 2019 [accessed 2019 Nov 6]. https://harmreduction.org/about-us/principles-of-harm-reduction/.
- Wagner KD, Valente TW, Casanova M, Partovi SM, Mendenhall BM, Hundley JH, Gonzalez M, Unger JB. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. International Journal of Drug Policy. 2010 May; 21(3):186–93. doi:10.1016/j.drugpo.2009.01.003.